Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Open-Label Randomized Study of Anti-Viral Antibiotic Therapy With and Without Familial (Maternal) Cytomegalovirus (CMV) Cytotoxic T Lymphocytes (CTLs) in Neonates With Moderate/Severe Maternal Acquired CMV Infection

NCT05564598 is registered in ClinicalTrials.gov with New York Medical College as lead sponsor.

NCT NCT05564598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05564598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Open-Label Randomized Study of Anti-Viral Antibiotic Therapy With and Without Familial (Maternal) Cytomegalovirus (CMV) Cytotoxic T Lymphocytes (CTLs) in Neonates With Moderate/Severe Maternal Acquired CMV Infection
Lead sponsor
New York Medical College
Phase
Phase 2
Overall status
Recruiting
Start date
July 1, 2023
Completion date
October 31, 2028
Enrollment
23 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

congenital cytomegaloviral (cmv) disease